Does aprotinin increase the myocardial damage in the setting of ischemia and preconditioning?
- 1 August 1995
- journal article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 60 (2) , 307-310
- https://doi.org/10.1016/0003-4975(95)00398-5
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Preconditioning: state of the art myocardial protectionCardiovascular Research, 1993
- Aprotinin in perspectiveThe Annals of Thoracic Surgery, 1993
- Ischemic preconditioning increases adenosine release and 5'-nucleotidase activity during myocardial ischemia and reperfusion in dogs. Implications for myocardial salvage.Circulation, 1993
- Aprotinin therapy for reoperative myocardial revascularization: A placebo-controlled studyThe Annals of Thoracic Surgery, 1992
- High-dose aprotinin in cardiac surgery: Three years' experience in 1,784 patientsJournal of Cardiothoracic and Vascular Anesthesia, 1992
- High-dose aprotinin therapy: A review of the first five years' experienceJournal of Cardiothoracic and Vascular Anesthesia, 1992
- The Role of Protein C as an Inhibitor of Blood Clotting During Extracorporeal CirculationThe Thoracic and Cardiovascular Surgeon, 1991
- Inhibition of activated protein C by aprotinin and the use of the insolubilized inhibitor for its purificationThrombosis Research, 1990
- Adenosine inhibits exocytotic release of endogenous noradrenaline in rat heart: a protective mechanism in early myocardial ischemia.Circulation Research, 1987
- Regulation of adenosine formation by the heart.Circulation Research, 1986